Clinical Trial Update: A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Revlimid (lenalidomide) plus dexamethasone versus dexamethasone alone in previously treated multiple myeloma; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-03-04